Overview
David Benton is a Hematologist and an Oncologist in Portsmouth, New Hampshire. Dr. Benton is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Polycythemia Vera.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
155 Borthwick Ave, Suite C, Portsmouth, NH 03801
105 Topsham Fair Mall Rd, Unit 1, Topsham, ME 04086
Additional Areas of Focus
Dr. Benton has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Massachusetts General Physicians Organization Inc
Jeremy Abramson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Dana-Farber Cancer Institute, Breast Oncology Program
Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School. She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer. She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials. Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer.
Massachusetts General Physicians Organization Inc
David Sykes is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Sykes is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Agranulocytosis, Chronic Familial Neutropenia, Polycythemia Vera, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Sykes is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Benton isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Benton isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Benton isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Benton isDistinguished. Learn about Familial Prostate Cancer.
- Lung CancerDr. Benton isDistinguished. Learn about Lung Cancer.
- Multiple MyelomaDr. Benton isDistinguished. Learn about Multiple Myeloma.
- Advanced
- AgranulocytosisDr. Benton isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Benton isAdvanced. Learn about Breast Cancer.
- Burkitt LymphomaDr. Benton isAdvanced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Benton isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Benton isAdvanced. Learn about Chronic Familial Neutropenia.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Benton isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Benton isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Benton isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adrenal CancerDr. Benton isExperienced. Learn about Adrenal Cancer.
